Sangamo Therapeutics, Inc. (SGMO)
0.3917
+0.01
(+1.79%)
USD |
NASDAQ |
Feb 23, 16:00
0.3865
-0.01
(-1.33%)
After-Hours: 06:34
Sangamo Therapeutics EPS Diluted (Quarterly) : -0.1148 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.93M |
| Revenue (Quarterly) | 0.581M |
| Total Expenses (Quarterly) | 35.51M |
| Enterprise Value | 126.70M |
| Gross Profit Margin (Quarterly) | -226.7% |
| Profit Margin (Quarterly) | -6.01K% |
| Earnings Yield | -113.0% |
| Normalized Earnings Yield | -113.15 |